Free Trial
NASDAQ:IMAC

IMAC (IMAC) Stock Price, News & Analysis

IMAC logo
$0.0006 0.00 (0.00%)
As of 10/15/2026

About IMAC Stock (NASDAQ:IMAC)

Advanced

Key Stats

Today's Range
$0.0006
▼
$0.0006
50-Day Range
N/A
52-Week Range
$0.75
▼
$1.65
Volume
1 shs
Average Volume
708,132 shs
Market Capitalization
$15.89 thousand
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

IMAC Holdings, Inc. was a U.S. healthcare company that operated outpatient medical centers under the IMAC Regeneration Centers brand. Its business focused on non-surgical orthopedic care, regenerative medicine, physical therapy, chiropractic services, and related rehabilitation treatments.

The company’s centers were designed to treat musculoskeletal conditions, sports injuries, joint pain, and other orthopedic and mobility-related concerns. Services included physician consultations, diagnostic evaluations, rehabilitation programs, and therapies intended to help patients manage pain and improve function without or before surgery.

IMAC Holdings served patients through a network of outpatient facilities in the United States. The company was formerly publicly traded on the Nasdaq under the symbol IMAC; however, publicly available information about its current operating status, leadership, and geographic footprint is limited.

AI Generated. May Contain Errors.

Receive IMAC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for IMAC and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

IMAC Stock News Headlines

Apple HomeView: I loved the iMac G4 too
Undiscovered Sub-$1 Gold-Silver Royalty Stock Takes Flight
A small-cap gold and silver royalty company is generating record revenue from producing mines, yet shares still trade under 1 dollar. It just signed the largest transaction in its history, a new gold streaming deal backed by a strategic relationship with a major mining investment firm. A well-known sector financier has invested his own money and joins the CEO in an exclusive interview breaking down the full story.tc pixel
See More Headlines

IMAC Stock Analysis - Frequently Asked Questions

IMAC's stock was trading at $0.1389 at the beginning of 2026. Since then, IMAC stock has decreased by 99.6% and is now trading at $0.0006.

IMAC Holdings, Inc. (NASDAQ:IMAC) released its quarterly earnings data on Thursday, April, 14th. The company reported ($0.11) earnings per share for the quarter, missing the consensus estimate of ($0.09) by $0.03. IMAC had a negative trailing twelve-month return on equity of 52.17% and a negative net margin of 75.40%.

IMAC (IMAC) raised $4 million in an initial public offering on the week of February 11th 2019. The company issued 900,000 shares at $5.00 per share. Dawson James Securities and Cuttone served as the underwriters for the IPO.

Shares of IMAC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that IMAC investors own include iBio (IBIO), Viking Therapeutics (VKTX), Bionano Genomics (BNGO), FuelCell Energy (FCEL), Advanced Micro Devices (AMD), Assertio (ASRT) and Atossa Genetics (ATOS).

Company Calendar

Last Earnings
4/14/2022
Today
10/16/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Healthcare Providers & Services
Sub-Industry
N/A
Current Symbol
NASDAQ:IMAC
CIK
1729944
Fax
N/A
Employees
106
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($0.27)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$10.54 million
Net Margins
-75.40%
Pretax Margin
-75.40%
Return on Equity
-52.17%
Return on Assets
-34.51%

Debt

Debt-to-Equity Ratio
0.01
Current Ratio
1.27
Quick Ratio
1.27

Sales & Book Value

Annual Sales
$15.22 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.69 per share
Price / Book
0.00

Miscellaneous

Outstanding Shares
26,485,000
Free Float
23,837,000
Market Cap
$15.89 thousand
Optionable
Not Optionable
Beta
-0.88
The 7 Hottest IPO Stories of 2026 Cover

MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.

Get This Free Report

This page (NASDAQ:IMAC) was last updated on 10/15/2026 by MarketBeat.com Staff.
From Our Partners